Location History:
- Akarp, SE (2011 - 2013)
- Lund, SE (2011 - 2017)
Company Filing History:
4 out of 1,500 
4 out of 378 
2 out of 192 
Years Active: 2011-2017
Title: Jan Dahmen: Innovator in Pharmaceutical Chemistry
Introduction
Jan Dahmen is a prominent inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on novel compounds that have potential applications in medicine.
Latest Patents
Among his latest patents, Jan Dahmen has developed phenyl and benzodioxinyl substituted indazoles derivatives. These compounds are described by a specific formula and relate to novel indazolyl derivatives. The present invention encompasses pharmaceutical compositions that include these derivatives, processes for their preparation, and their use as medicaments.
Career Highlights
Throughout his career, Jan Dahmen has worked with notable companies in the pharmaceutical industry, including AstraZeneca AB and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in healthcare.
Collaborations
Jan has collaborated with esteemed colleagues such as Markus Berger and Hartmut Rehwinkel. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical compounds.
Conclusion
Jan Dahmen's work exemplifies the impact of innovation in pharmaceutical chemistry. His patents and collaborations reflect a commitment to advancing medical science through novel compounds.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.